课题基金 / 基金详情

LISTERIA AND SHIGELLA USE HOST CELL ACTIN

LISTERIA AND SHIGELLA USE HOST CELL ACTIN
李斯特菌和志贺氏菌使用宿主细胞肌动蛋白
批准号:
6766793
负责人:
Frederick s Southwick
金额:
$28.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-07-01 至 2007-05-31

项目摘要

项目成果

Frederick s Southwick的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The gram-positive bacillus Listeria monocytogenes predominantly infects immunocompromised patients, causing bacteremia and meningitis while the gram-negative bacillus Shigella flexneri infects normal hosts causing severe diarrhea and dehydration. The pathogenesis of Listeriosis and Shigellosis absolutely requires these intracellular bacteria to usurp the host cell's contractile system. Listeria and Shigella induce host cell actin to assemble into rocket tails that rapidly propel the bacteria through the cytoplasm, allowing their cell-to-cell spread and avoidance of the humoral immune system. Actin assembly occurs in a discrete polymerization zone directly behind the motile bacteria. This region blocks the host cell actin-regulatory proteins, gelsolin, CapZ and CapG, that normally cap the fast growing ends of actin filaments. This blocking activity allows actin filaments to rapidly assemble in this discrete zone. Two of these proteins, gelsolin and CapG, require micromolar calcium to function. We will: Aim I - Elucidate how Listeria blocks barbed end-capping proteins in the polymerization zone. Pyrenyl actin and right angle light scattering will be used to examine how profilin combined PIP2 and VASP or N-WASP effects actin filament capping by CapG, CapZ and gelsolin. Capping inhibition by Listeria will be investigated in brain cell free extracts before and after depletion of profilin and VASP. Localization of PIP2 (well known to block capping activity) in Listeria and Shigella infected cells will be studied using a GFP labeled probe. The effects of blocking PIP2 production using the PI kinase inhibitors Wortmannin and quercetin, infecting cells with Listeria ActA mutants lacking PIP2 binding sites, and ActA mutants lacking VASP binding sites will be examined. Aim II - Study the Calcium-Dependence of Listeria and Shigella actin-based motility. Calcium is a critical signal for turning on and off actin regulatory proteins, and we have found that the chelator BAPTAM blocks Shigella actin-based motility and slows the disassembly of Listeria rocket tails. The Ca2+-sensitivity of N-WASP and vinculin, cell proteins unique to Shigella-induced actin assembly, as well as gelsolin will be studied. These investigations should clarify key regulatory pathways required for Listeria- and Shigella-induced actin assembly and may identify new therapeutic targets for treating Listeriosis and Shigellosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Actin Filament Formation in Phagocytes
  • 批准号:
    8090809
  • 项目类别:
  • 资助金额:
    $24.04万
  • 财政年份:
    2010
  • 负责人:
    Frederick s Southwick
  • 依托单位:
Anthrax Toxins Impair Phagocyte Actin-based Motility
  • 批准号:
    7469409
  • 项目类别:
  • 资助金额:
    $23.91万
  • 财政年份:
    2006
  • 负责人:
    Frederick s Southwick
  • 依托单位:
Anthrax Toxins Impair Phagocyte Actin-based Motility
  • 批准号:
    7890545
  • 项目类别:
  • 资助金额:
    $23.55万
  • 财政年份:
    2006
  • 负责人:
    Frederick s Southwick
  • 依托单位:
Anthrax Toxins Impair Phagocyte Actin-based Motility
  • 批准号:
    7148643
  • 项目类别:
  • 资助金额:
    $30.19万
  • 财政年份:
    2006
  • 负责人:
    Frederick s Southwick
  • 依托单位:
国内基金
海外基金
Shigella sp. PIB菌产生长链脂肪酸诱发顽固性功能性便秘的机制研究
  • 批准号:
    32371176
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    陈鑫
  • 依托单位:
IBD原籍菌Shigella通过Neu5Ac碳源竞争拮抗外源Faecalibacterium定植导致FMT后肠黏膜修复抑制的机制研究
  • 批准号:
    82300753
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    王新军
  • 依托单位:
Shigella sp. PIB细菌感染导致顽固性功能性便秘的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
  • 依托单位:
顽固性功能性便秘致病菌Shigella sp PIB溯源和分子流行病学研究
  • 批准号:
    82250003
  • 项目类别:
    专项项目 国家自然科学基金外国青年学者研究基金
  • 资助金额:
    300.00万元
  • 批准年份:
    2022
  • 负责人:
    朱敏生
  • 依托单位: